前收市價 | 23.73 |
開市 | 23.84 |
買盤 | 24.11 x 34800 |
賣出價 | 24.13 x 34700 |
今日波幅 | 23.84 - 24.45 |
52 週波幅 | 16.15 - 28.04 |
成交量 | |
平均成交量 | 1,932 |
市值 | 23.32B |
Beta 值 (5 年,每月) | 0.69 |
市盈率 (最近 12 個月) | 無 |
每股盈利 (最近 12 個月) | -0.83 |
業績公佈日 | 2024年7月29日 |
遠期股息及收益率 | 無 (無) |
除息日 | 2022年5月12日 |
1 年預測目標價 | 無 |
Royal Philips NV (NYSE:PHG) shares are trading higher on Wednesday. Italy's famous Agnelli family has increased its investment in Philips, showcasing a robust vote of confidence in the Dutch firm known for its medical devices. Through Exor NV, the family's holding company, the Agnellis now controls 17.51% of Philips, enhancing their position as the company's largest shareholder, an increase from 16.1% recorded in May. This expansion in their stake is indicative of growing trust in Philips' marke
Philips (PHG) boosts Diagnosis & Treatment on the back of Precision Diagnosis and Image-Guided Therapy businesses and an expanding partner base.
Philips (PHG) boosts its Image-Guided Therapy portfolio with the Duo Venous Stent System, strengthening its Diagnosis & Treatment segment.